Cargando…

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator

Ventricular arrhythmias are a therapeutic challenge, owing to their relatively unpredictable and deadly nature. Many patients are treated with an implantable cardioverter-defibrillator for either primary or secondary prevention of ventricular arrhythmias, meaning those who are at high risk of versus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Back, Steven H, Kowey, Peter R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2019
Materias:	Clinical Arrhythmias
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528055/ https://www.ncbi.nlm.nih.gov/pubmed/31114683 http://dx.doi.org/10.15420/aer.2018.55.5

Ejemplares similares

Monomorphic Ventricular Arrhythmias in Athletes
por: Hsu, Jeffrey J, et al.
Publicado: (2019)

Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death
por: Kuehn, Christian, et al.
Publicado: (2022)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks
por: Fleeman, Blake E., et al.
Publicado: (2019)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014)

Electrocardiographic Criteria for Differentiating Left from Right Idiopathic Outflow Tract Ventricular Arrhythmias
por: Mariani, Marco V, et al.
Publicado: (2021)

Ventricular arrhythmia management in patients with genetic cardiomyopathies
por: Sharif, Zain I., et al.
Publicado: (2021)

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillator
por: Ishida, Yuji, et al.
Publicado: (2020)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Recurrent implantable cardioverter-defibrillator shocks due to automatic deactivation of a right ventricular lead noise discrimination algorithm
por: Seiler, Thomas, et al.
Publicado: (2022)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
por: Kiamanesh, Omid, et al.
Publicado: (2015)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
por: Park, Y M, et al.
Publicado: (2023)

Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
por: Agarwal, Manyoo A, et al.
Publicado: (2023)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
por: Shehadeh, Malik, et al.
Publicado: (2020)

Management of ventricular arrhythmias in heart failure: Current perspectives
por: Peichl, Petr, et al.
Publicado: (2021)

Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
por: Choi, In Su, et al.
Publicado: (2021)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
por: Jin, Jifu, et al.
Publicado: (2023)

Association of pre–left ventricular assist device defibrillator shocks for ventricular arrhythmia with clinical outcomes after left ventricular assist device implantation
por: Wann, Daniel G., et al.
Publicado: (2023)

Risk factors for atrial arrhythmia recurrence after atrial arrhythmia surgery with pulmonary valve replacement
por: Tominaga, Yuji, et al.
Publicado: (2023)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes
por: Conte, Giulio, et al.
Publicado: (2019)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Plastiras, Sotiris C, et al.
Publicado: (2021)

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ldnn06e72bcncihr9dqmd9t1f4